Published in Lab Business Week, March 2nd, 2008
The tablets being tested in the study utilize the same improved solid dosage form of Unigene's Enteripep(R) oral delivery technology used in Unigene's prior oral calcitonin study that was completed last fall. In that study, the new dosage form achieved a biological response...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.